Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study.

Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study.

Serum type II secretory phospholipase A(2) (sPLA(2)-IIa) has been found to be predictive of adverse outcomes in patients with stable coronary heart disease. Compounds targeting sPLA(2)-IIa are already under development. This study investigated if an association of sPLA(2)-IIa with secondary cardiova...

Full description

Bibliographic Details
Main Authors: Lutz P Breitling, Wolfgang Koenig, Marcus Fischer, Ziad Mallat, Christian Hengstenberg, Dietrich Rothenbacher, Hermann Brenner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3142130?pdf=render

Internet

http://europepmc.org/articles/PMC3142130?pdf=render

Similar Items